Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BAP1 mutations in high-grade meningioma: implications for patient care
Ganesh M. Shankar, Sandro Santagata
Neuro-Oncology (2017) Vol. 19, Iss. 11, pp. 1447-1456
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system
Simon Gritsch, Tracy T. Batchelor, L. Nicolas Gonzalez Castro
Cancer (2021) Vol. 128, Iss. 1, pp. 47-58
Open Access | Times Cited: 252
Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer
Michele Carbone, J. William Harbour, James Brugarolas, et al.
Cancer Discovery (2020) Vol. 10, Iss. 8, pp. 1103-1120
Open Access | Times Cited: 202
Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions
Christian Ogasawara, Brandon Philbrick, D. Cory Adamson
Biomedicines (2021) Vol. 9, Iss. 3, pp. 319-319
Open Access | Times Cited: 194
Advances in meningioma genetics: novel therapeutic opportunities
Matthias Preusser, Priscilla K. Brastianos, Christian Mawrin
Nature Reviews Neurology (2018) Vol. 14, Iss. 2, pp. 106-115
Closed Access | Times Cited: 184
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Abrar Choudhury, Stephen T. Magill, Charlotte Eaton, et al.
Nature Genetics (2022) Vol. 54, Iss. 5, pp. 649-659
Open Access | Times Cited: 174
Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, et al.
CNS Oncology (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 117
Signaling pathways in brain tumors and therapeutic interventions
Shenglan Li, Can Wang, Jinyi Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 52
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 26
Advances in multidisciplinary therapy for meningiomas
Priscilla K. Brastianos, Evanthia Galanis, Nicholas Butowski, et al.
Neuro-Oncology (2018) Vol. 21, Iss. Supplement_1, pp. i18-i31
Open Access | Times Cited: 137
Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas
Mark W. Youngblood, Daniel Durán, Julio D. Montejo, et al.
Journal of neurosurgery (2019) Vol. 133, Iss. 5, pp. 1345-1354
Closed Access | Times Cited: 136
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Leah M. Katz, Thomas Hielscher, Benjamin Liechty, et al.
Acta Neuropathologica (2018) Vol. 135, Iss. 6, pp. 955-963
Open Access | Times Cited: 131
Meningioma: A Review of Clinicopathological and Molecular Aspects
Kristin Huntoon, Angus Toland, Sonika Dahiya
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 114
Molecular and translational advances in meningiomas
Suganth Suppiah, Farshad Nassiri, Wenya Linda Bi, et al.
Neuro-Oncology (2018) Vol. 21, Iss. Supplement_1, pp. i4-i17
Open Access | Times Cited: 112
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
Tareq A. Juratli, Christian Thiede, Mara V.A. Koerner, et al.
Oncotarget (2017) Vol. 8, Iss. 65, pp. 109228-109237
Open Access | Times Cited: 103
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A. Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 80
Molecular alterations in meningioma: prognostic and therapeutic perspectives
Cristina Birzu, Matthieu Peyre, Felix Sahm
Current Opinion in Oncology (2020) Vol. 32, Iss. 6, pp. 613-622
Closed Access | Times Cited: 72
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
Priscilla K. Brastianos, Erin Twohy, Elizabeth R. Gerstner, et al.
Journal of Clinical Oncology (2022) Vol. 41, Iss. 3, pp. 618-628
Open Access | Times Cited: 62
Pathology of the Tumors of the Central Nervous System
Redi Bumci, Ioannis Parthymos, Constantinos Zamboglou, et al.
Springer eBooks (2023), pp. 71-110
Closed Access | Times Cited: 22
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto‐Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1121-1133
Open Access | Times Cited: 14
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors
Jordan R. Hansford, Anirban Das, Rose B. McGee, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 11, pp. 2342-2350
Open Access | Times Cited: 11
Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease
Keith M. Kerr, Krista J. Qualmann, Yoshua Esquenazi, et al.
Neurosurgery (2018) Vol. 83, Iss. 6, pp. 1107-1118
Open Access | Times Cited: 73
Molecular characteristics of meningiomas
Young Suk Lee, Youn Soo Lee
Journal of Pathology and Translational Medicine (2020) Vol. 54, Iss. 1, pp. 45-63
Open Access | Times Cited: 66
The Hippo Pathway as a Driver of Select Human Cancers
Aishwarya Kulkarni, Matthew T. Chang, Joseph H.A. Vissers, et al.
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 781-796
Closed Access | Times Cited: 66
Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management
Taylor Wilson, Lei Huang, Dinesh Ramanathan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top